Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $182.27 | 6 | 97.1% |
| Education | $5.38 | 2 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Chiesi USA, Inc. | $115.23 | 1 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $22.21 | 4 | $0 (2017) |
| Phathom Pharmaceuticals, Inc. | $17.41 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $16.80 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $16.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.21 | 3 | Phathom Pharmaceuticals, Inc. ($17.41) |
| 2017 | $137.44 | 5 | Chiesi USA, Inc. ($115.23) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: RESPIRATORY | ||||||
| 04/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.80 | General |
| 09/28/2017 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $115.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/09/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: RESPIRATORY | ||||||
| 06/29/2017 | Sunovion Pharmaceuticals Inc. | SEEBRI (Drug) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 04/19/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 305 | 586 | $90,937 | $35,826 |
| 2022 | 7 | 436 | 812 | $116,924 | $47,661 |
| 2021 | 5 | 461 | 867 | $119,773 | $52,491 |
| 2020 | 6 | 551 | 990 | $139,237 | $48,893 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 169 | 396 | $62,703 | $25,782 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 100 | 146 | $15,005 | $6,666 | 44.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 23 | 23 | $8,394 | $2,910 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 21 | $4,834 | $468.35 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 189 | 491 | $76,087 | $31,684 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 121 | 183 | $18,501 | $8,852 | 47.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 17 | 17 | $5,995 | $2,207 | 36.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 30 | 33 | $5,156 | $1,566 | 30.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Facility | 2022 | 11 | 11 | $2,649 | $1,249 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 21 | $2,618 | $660.93 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 14 | $2,772 | $545.69 | 19.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 18 | 18 | $914.76 | $487.33 | 53.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2022 | 21 | 24 | $2,230 | $409.23 | 18.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 241 | 559 | $80,790 | $37,225 | 46.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 122 | 184 | $17,441 | $8,760 | 50.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 27 | 27 | $9,314 | $3,565 | 38.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 39 | 57 | $8,618 | $2,209 | 25.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 32 | 40 | $3,610 | $731.23 | 20.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 218 | 490 | $71,470 | $26,297 | 36.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 140 | 245 | $23,279 | $8,171 | 35.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2020 | 69 | 69 | $23,134 | $7,897 | 34.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 67 | 110 | $14,452 | $4,363 | 30.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 43 | 59 | $4,084 | $1,200 | 29.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 14 | 17 | $2,818 | $964.53 | 34.2% |
About Dr. Anna Marie Ward, MD
Dr. Anna Marie Ward, MD is a Family Medicine healthcare provider based in Norwich, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154402808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Marie Ward, MD has received a total of $187.65 in payments from pharmaceutical and medical device companies, with $50.21 received in 2024. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($182.27).
As a Medicare-enrolled provider, Ward has provided services to 1,753 Medicare beneficiaries, totaling 3,255 services with total Medicare billing of $184,871. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Norwich, NY
- Active Since 10/18/2006
- Last Updated 02/21/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1154402808
Products in Payments
- CLEVIPREX (Drug) $115.23
- VOQUEZNA (Drug) $17.41
- TRELEGY ELLIPTA (Drug) $16.00
- UTIBRON (Drug) $15.61
- SEEBRI (Drug) $6.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Norwich
Jessica Bailey Deblois, Aprn, Fnp-C, APRN, FNP-C
Family Medicine — Payments: $4,018
Christopher Kolker, Md, MD
Family Medicine — Payments: $3,784
William Hernandez, Md, MD
Family Medicine — Payments: $1,270
Paul Mcfarlane, Md, MD
Family Medicine — Payments: $1,180
Shamika Gokhale, Do, DO
Family Medicine — Payments: $171.19
Kristina Hummer, Do, DO
Family Medicine — Payments: $101.14